Problems and future directions for quality evaluation of the Health Insurance Review and Assessment Service

Abstract

© Korean Medical Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. In 2014, there were disagreements between the Value Incentive Program (VIP) of the Health Insurance Review and Assessment Service (HIRA) and academic societies. The primary differences of opinion arose over acute myocardial infarction and stroke, which are the first disease targets of the VIP. The quality of healthcare is one of the three components of the iron triangle in healthcare policy. Improving the quality of care requires effort from both internal approach(medical community) and external approach. The scope of HIRA for improving and monitoring the quality of care could be widened because (as of 2012) HIRA deals with only 16 items of quality improvement and assessment; does not monitor the total scope of medical services, patient safety, and patient experiences; and the VIP of HIRA is contains solely a quality dimension without a cost dimension. Therefore, HIRA should cooperate with medical communities to effectively improve the quality of care and expand procedures for quality improvement, assessment, and monitoring. HIRA must keep in mind that, with regard to improvement of quality of care, its role is not regulatory in nature, but cooperative.